Crude preparations of lysyl hydroxylase were extracted from chick-embryo tendons synthesizing exclusively type I collagen, chick-embryo sterna synthesizing exclusively type II collagen and HT-1080 sarcoma cells synthesizing exclusively type IV collagen. No differences were found in the Km values for Fe2+, 2-oxoglutarate and ascorbate between these three enzyme preparations. Similarly no differences were found in the Km values for type I and type II protocollagens and the rate at which type IV protocollagen is hydroxylated between these enzyme preparations. The extent to which type I protocollagen could be hydroxylated by the three enzymes was likewise identical. These data strongly argue against the existence of collagen-type-specific lysyl hydroxylase isoenzymes.
Lysyl hydroxylase (peptidyl-lysine, 2-oxoglutarate:oxygen 5-oxidoreductase, EC 1.14.11.4) catalyses the synthesis of hydroxylysine in collagen by the hydroxylation of lysyl residues in peptidyl linkages. The reaction occurs as a post-translational modification and requires 2-oxoglutarate, molecular oxygen, Fe2+ ions and ascorbate. The hydroxy groups of the hydroxylysyl residues serve as the sites of attachment for carbohydrate units and they are important in stabilizing the intramolecular collagen cross-links (for recent review, see . The extent of lysyl hydroxylation varies in different collagen types and within the same type from different tissues (Kivirikko & Myllylii, 1980) , as also does the lysyl hydroxylation defect encountered in the type VI variant of the EhlersDanlos syndrome (Pinnell et al., 1972; Krane, 1980) . One reason for these differences might be the existence of collagen-type-specific or tissue-specific lysyl hydroxylase isoenzymes.
On the other hand, lysyl hydroxylases purified to homogeneity from chick embryos and human placental tissues and to essential homogeneity from human foetal tissues (Turpeenniemi-Hujanen et al., 1980 , 1981 have an identical molecular weight for the subunit and identical kinetic constants for the co-substrates when determined with type I protocollagen as the substrate (Puistola et al., 1980; Turpeenniemi-Hujanen et al., 1981) . Additionally, no significant immunological differences have been found between the lysyl hydroxylases from whole chick embryo, chick-embryo tendon, cartilage and Vol. 201 kidneys in double immunodiffusion and antiseruminhibition studies (Turpeenniemi-Hujanen, 1981) .
The present work studies the catalytic properties of Iysyl hydroxylases from chick-embryo tendons synthesizing exclusively type I collagen (see Bornstein & Sage, 1980) , chick-embryo sterna synthesizing exclusively type II collagen (Bornstein & Sage, 1980) and human HT-1080 sarcoma cells synthesizing exclusively type IV collagen Pihlajaniemi et al., 1981) . The The lysyl hydroxylase referred to as the 'type IV' enzyme was isolated from HT-1080 sarcoma cells grown in 75 cm2 plastic tissue-culture bottles in a total volume of 20ml at 370C in a humidified incubator with an atmosphere of air/CO2 (19:1). The medium was Dulbecco's modification of Eagle's medium supplemented with 10% (v/v) newborn-calf serum, 50pg of ascorbic acid/ml added daily, 50 units of penicillin/ml and 50,ug of streptomycin/ ml. The cells were harvested by trypsin treatment in Krebs medium. The cell pellet was isolated by centrifugation at 600g for 3min and washed three times with 10% newborn-calf serum in Krebs solution. The cells were homogenized in the homogenization buffer described above with a Teflon/ glass homogenizer and centrifuged at 150OOg for 30min at 40C. The supernatant was used as the enzyme.
Preparation ofprotocollagen substrates
The protocollagen substrates were prepared from 16-day chick-embryo tendon cells, 15-day chickembryo sterna cells and cultured HT-1080 sarcoma cells according to the principles described previously (Risteli & Kivirikko, 1976) , except that DL-[6-3H(n)Ilysine was used instead of [14C]lysine. The leg tendons or sterna of the chick embryos were dissected and the cells isolated by controlled digestion' with trypsin and purified bacterial collagenase (Dehm & Prockop, 1972) and then filtered through lens paper. The liberated tendon and sternum cells, and also the HT-1080 sarcoma cells, which were harvested with trypsin, were washed three times with modified Krebs medium containing 10% newborn-calf serum (Dehm & Prockop, 1972; Berg & Prockop, 1973) .
The cells were incubated at 370C in modified Krebs medium (Dehm & Prockop, 1972) containing 5% newborn-calf serum, preincubated with aa'-bipyridine for 25 min and pulsed with 500,uCi of DL-[6-3H(n)Ilysine for 3 h for the tendon cells, 1.5 h for the sternum cells and 2 h for the HT-1080 sarcoma cells. The cells were homogenized and the protocollagen synthesized was partially purified by acetic acid extraction (Berg & Prockop, 1973) . These protocollagen substrates are referred to as 'type I', 'type II' and 'type IV' substrates respectively. The specific radioactivity of the free lysine pool was measured and that of each substrate preparation calculated as described by Breul et al. (1980) .
Assay oflysyl hydroxylase activity
Lysyl hydroxylase activity was assayed by incubating the 15 000g supernatants with different DL-[6-3H(n)Ilysine-labelled protocollagen substrates for 30min at 37°C in a final volume of Iml containing 0.05 mM-FeSO4, 0.5 mM-2-oxoglutarate, 1.OmM-ascorbic acid, 0.1 mg of catalase (Calbiochem), 0.1 mM-dithiothreitol (Calbiochem), 1.5 mg of bovine serum albumin (Sigma) and 50mM-Tris/HCI buffer adjusted to pH 7.8 at 25°C.
The reaction was carried out as described previously (Kivirikko & Prockop, 1972; Puistola et al., 1980 (Plowman, 1972; Puistola et al., 1980 from the data obtained in initial-velocity studies and calculated from the primary plots (Plowman, 1972; Puistola et al., 1980) . No differences were seen between the Km values in respect of the type-I or type-IT protocollagen substrates for any of the three enzyme preparations (Table 2) .
Owing to technical difficulties encountered in preparing large amounts of type IV protocollagen, Km values were not determined for this substrate. However, when the same amounts of activity units of the 'type I', 'TI' and 'IV' enzymes were taken, as tested with type-I protocollagen substrate, and these samples were assayed with type-IV protocollagen substrate, identical amounts of the activity units Enzyme activity (munits) Fig. 3 . Hydroxylation of type I protocollagen with 'type I', 'II' and 'IV' lysyl hydroxylases DL-[6-3H(n)]Lysine-labelled protocollagen type-I substrate from chick-embryo tendon cells (3.4 nmol) was hydroxylated with lysyl hydroxylase from chick-embryo tendons (type I) (0), chick-embryo sterna (type II) (A) and HT-1080 sarcoma cells (type IV) (0). Lysyl hydroxylation was measured as d.p.m./30min, one unit of enzyme activity being defined as the amount of enzyme present in 1 mg of the (NH4)2SO4 fraction (17-55% saturation) obtained from the 1500Og supernatant of chickembryo homogenate (Kivirikko & Prockop, 1972; Turpeenniemi-Hujanen et al., 1980) .
were again found in these three enzyme preparations (Table 3) . Similarly, when the same amounts of type-I protocollagen substrate were hydroxylated with the 'type I', 'II' and 'IV' enzymes, no differences were seen in the extent to which the type I protocollagen could be hydroxylated (Fig. 3) .
Discussion
The present data indicate that the Km values for type I and type II protocollagens and the rate at which type IV protocollagen is hydroxylated are identical for crude lysyl hydroxylase preparations from cells synthesizing exclusively type I, II or IV collagen. The extent to which type I protocollagen can be hydroxylated with lysyl hydroxylase from these three sources was likewise found to be identical. Additional similarity in the catalytic properties of these three enzyme preparations was found in that the Km values for Fe2+, 2-oxoglutarate and ascorbate were identical within the limits of experimental error. The Km values determined here for the co-factors and co-substrates and with respect to the type-I protocollagen substrate are also very similar to those previously determined for purified or pure lysyl hydroxylase from chick embryos (Ryhiinen & Kivirikko, 1974; Puistola et al., 1980) and human placental tissues (Turpeenniemi-Hujanen et al., 1981) and for crude lysyl hydroxylase from cells of a patient with the type VI variant of the Ehlers-Danlos syndrome (Turpeenniemi-Hujanen et al., 1981) . These data strongly argue against the existence of collagen type-specific lysyl hydroxylase isoenzymes.
Recent studies on the characterization of lysyl hydroxylase by using antiserum against the pure enzyme from chick embryos have indicated that various tissues of the embryo contain an immunologically similar enzyme form when studied by immunodiffusion, and that essentially identical amounts of the antiserum are required for 40% inhibition of the same amount of lysyl hydroxylase activity units from a number of tissues (Turpeenniemi-Hujanen, 1981) . These data together with the present results make it highly unlikely that lysyl hydroxylase has collagen-type-specific or tissuespecific isoenzymes with significantly different catalytic or molecular properties. Nevertheless, additional studies with other techniques would be 1982 Table 3 . Hydroxylysineformation in type I and type IVprotocollagen with 'type I', 'II' and 'IV' lysyl hydroxylases The activity of 'type I', 'II' and 'IV' enzymes was tested with type-I protocollagen substrate from chick-embryo tendon cells. The same amounts of activity units of the three enzymes were taken and assayed with type-IV protocollagen substrate from HT-1080 sarcoma cells.
Hydroxylysine required to demonstrate whether lysyl hydroxylase has any isoenzymes at all.
On the basis of the above conclusions it seems likely that the differences in the extents of lysyl hydroxylation between the genetically distinct collagen types are due to regulation of the amounts of a single type of the enzyme protein in various cells. This would agree with data indicating that differences in the extent of lysyl hydroxylation between type I, II and IV protocollagens can be explained to a large extent by differences in the amounts of lysyl hydroxylase activity in cells synthesizing exclusively one of these three collagen types (Risteli et al., 1979; Pihlajaniemi et al., 1981) , the assays being carried out with type-I protocollagen substrate.
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